Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Bad
|
New words:
additionalFosamaxlegal, adenosine, adoptedEITF, afferent, aided, allergy, alpha, AmerisourceBergen, andEmend, andFIN, andHyzaar, andHyzaarwill, andPropeciafor, andSingulair, andVarivaxdeclined, anemia, angina, anniversary, anomaly, Antonio, aortic, approvedEmend, approvedGardasilfor, asPreminent, asymptomatic, asZetia, asZocorandFosamaxafter, AvMed, bancin, Bancorp, Bench, BENCHMRK, beta, blocking, Boulder, breakdown, breath, Britain, broadly, broughtqui, BrownGreer, BRUN, budgetary, byVarivax, CA, capability, Cardinal, caspofungin, categorization, categorized, Cavanaugh, certiorari, CGRP, CIA, cited, claimVioxxcaused, clear, cleared, commensurate, comparedIsentressto, confirmatory, consultation, consumedVioxxand, consumption, corroborated, corruption, CrixivanandStocrin, CRP, custody, DC, Ddeclined, decedent, defect, defective, developmental, disrupt, disruption, distorted, distribuion, diverse, Dlost, doctor, drugVytorinand, echinocandin, economy, eighteen, elderly, elicit, employer, enjoin, escrow, exacerbated, Extinguishment, federalVioxx, femoral, Fifty, fit, fluctuation, forCosoptandTrusopt, forGardasilin, forPrimaxin, forProscarexpired, fosaprepitant, FSP, FSPEITF, FTC, fungal, genetic, Gerontological, Great, HBto, HBuntil, HDL, headquartered, healthy, HIB, hierarchy, highest, hip, hypoglycemia, identical, immunogenicity, immunology, imprudent, IMT, inadequacy, includeInvanzfor, includeMaxaltto, includeVarivax, increasingly, IND, indinavir, inducement, inflamed, influenzae, inFosamaxandFosamax, ingestedVioxxand, inJanuvia, injunctive, input, Insmed, insolvency, insufficient, interlocutory, intermittent, interruption, intrusion, inVioxx, inVioxxlabeling, IRO, Iroko, irrevocable, issuedEITF, issuedFSP, Janumet, Januviaand, JT, knew, launchingZostavaxoutside, LESLIE, Levine, London, loop, lumbar, makingTredaptiveavailable, managerial, manifesting, marketingVytorin, marketplace, McKesson, men, Michigan, midst, mild, misconduct, Missouri, mm, Montreal, morbidity, multicenter, Multidisciplinary, multistate, municipal, neuropeptide, ninety, nonforfeitable, nonsignificant, ofAggrastatin, ofEITF, ofFosamaxand, ofFosamaxfor, ofFSP, ofHyzaarin, ofIsentressand, ofIsentresswere, ofJanuviaandJanumetfor, ofPrimaxin, ofRecombivax, ofSingulairgrew, ofTredaptivein, ofVarivaxandZostavax, ofVarivaxwere, ofVytorinand, ofVytorinandZetiadeclined, ofVytorinandZetiafollowing, ofVytorinandZetiain, ofVytorinare, ofVytorincaused, ofVytorindeclined, ofVytorinon, ofVytorinwould, ofZetia, ofZetiadecreased, ofZetiathrough, ofZocorandProscarpost, ofZocordeclined, onEmend, Ontario, onZetiaandVytorin, opted, orderly, orphan, osteoanabolic, outsource, outsourcing, overlapping, Pan, pathophysiology, pegylated, pendency, peripheral, pervasive, pioglitazone, pivotal, Pomezia, PositionEITF, predicated, preemption, preliminarily, premature, PrimaxinandEmendprior, problem, Proscarlost, protocol, providingRotaTeqto, Queen, quickly, raltegravir, Ranking, reabsorption, reaction, reclassification, recurring, refratory, rehearing, rehearingen, relieved, reply, restraining, rizatriptan, rollforward, rolling, RotaTeqachieved, RotaTeqandZostavax, royalty, salt, sample, San, Sandoz, Saskatchewan, satisfied, science, Seattle, SeeRecently, sensing, Session, shipping, showedJanuviasignificantly, slowdown, smaller, sNDA, sophisticated, spine, Standardsbelow, STARTMRK, stimulating, strict, strike, subgroup, substitute, tabular, takingVytorincompared, takingVytorinor, talk, tamand, telcagepant, thatGardasilprevented, thatIsentressdid, thatPedvaxHIBandComvaxwill, thatProQuadwill, theFosamaxfranchise, theFosamaxmultidistrict, theJanuviaor, theory, theVioxxLigation, theVioxxsettlement, theVytorin, theVytorinstudy, thought, thousand, toAggrastat, Tobacco, toIsentressfollowing, tookVytorinhad, toRotaTeqand, tort, toVioxxmay, toVytorin, traditional, transient, triptan, Tsukuba, ultrasound, unavailability, unavailable, uncommon, uncured, unfair, UNICEF, unique, unobservable, unrelated, unstable, unsupported, uptake, urine, vaccineGardasil, valve, vasoconstriction, vertebral, virologic, wait, waiver, walk, Wegener, widow, withVytorin, withVytorinwould, writ, Wyeth, Zocorand, zolmitriptan
Removed:
administratively, AJCA, Amityville, anstice, Antigen, approvable, benchmark, bivalent, BMS, bowel, breadth, cancel, center, challenged, China, chosen, CIC, Clinic, conjugate, Cosopt, david, declared, depth, diagnostic, differentiated, discounting, drugsTrusoptandCosopt, encephalopathy, enforce, epilepsy, eventually, existence, finasteride, focusing, forAggrastatoutside, forest, formation, forming, forTrusoptandCosoptuntil, forVioxx, forVioxxlitigation, Geron, glaucoma, grow, Guilford, halt, Humeston, Hunterdon, improperly, inappropriately, incorporating, inCosopt, inflammatory, informed, infringe, initiation, insomnia, intervene, intervened, intraocular, inVioxxlegal, leaner, length, manufactured, marketingVioxx, Maryland, merged, metastasize, Mexico, mistrial, moderated, MRL, ocular, offer, ofNexiumandPrilosec, ofPepcid, ofPepcidin, ofPrilosecandNexium, ofVioxxProduct, Oregon, page, Park, Pharmacal, poultry, Prilosec, procedure, promote, Propecia, Proscar, qui, recall, reconsideration, refused, repatriate, repatriated, restated, retail, retrial, RotaTeq, scheme, seal, sealed, stake, Stem, stopped, tam, telomerase, telomere, theVioxxlegal, toll, tolling, toVioxxwill, transverse, treating, trivalent, Trusopt, unanimously, unknown, unsealing, Virginia, void, voted, Zealand
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 EX-10.3: Deferral Program
- 10.10 EX-10.10; Special Separation Program for "Separated" Employees
- 10.11 EX-10.11: Special Separation Program for "Bridged" Employees
- 10.12 EX-10.12: Special Separation Program for "Separated Retirement Eligible" Employees
- 10.16 EX-10.16: Supplemental Retirement Plan
- 10.18 EX-10.18: Plan for Deferred Payment of Directors's Compensation
- 12 EX-12: Computation of Ratios of Earnings to Fixed Charges
- 21 EX-21: Subsidiaries of Merck & Co., Inc.
- 24.1 EX-24.1: Power of Attorney
- 24.2 EX-24.2: Certified Resolution of Board of Directors
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certificaion
- 32.2 EX-32.2: Certification
- COVER Cover
Related press release
Merck Sharp & Dohme similar filings
Filing view
External links